Modest opioid withdrawal suppression efficacy of oral tramadol in humans

Lofwall, Michelle; Walsh, Sharon; Bigelow, George E.; Strain, Eric C.
October 2007
Psychopharmacology;Oct2007, Vol. 194 Issue 3, p381
Academic Journal
Tramadol is in an unscheduled atypical analgesic with low rates of diversion and abuse and mixed pharmacologic actions, including modest opioid agonist activity. The purpose of the current study was to characterize the opioid withdrawal suppression efficacy of oral tramadol. Residential, opioid-dependent adults ( n = 10) were maintained on morphine (15 mg subcutaneously, quad in diem) for approximately 6 weeks. Spontaneous opioid withdrawal was produced by substituting placebo for scheduled morphine doses 17.5 h before experimental sessions that occurred twice weekly. The acute effects of placebo, tramadol (50, 100, 200, and 400 mg orally), naloxone (0.1 and 0.2 mg intramuscularly [IM]), and morphine (15 and 30 mg IM) were tested under double-blind, double-dummy, randomized conditions. Outcomes included observer- and subject-rated measures, physiologic indices, and psychomotor/cognitive task performance. Naloxone and morphine produced prototypic opioid antagonist and agonist effects, respectively. Tramadol 50 and 100 mg produced effects most similar to placebo. Tramadol 200 and 400 mg initially produced significant dose-related increases in ratings of “bad effects” and “feel sick,” followed by evidence of opioid withdrawal suppression. Tramadol did not produce significant increases on measures of positive drug effects nor any clinically significant physiologic changes. Tramadol 200 and 400 mg show evidence of opioid withdrawal suppression without significant observer- and subject-rated opioid agonist effects. The profile of action did not suggest a high risk for tramadol abuse in opioid dependent individuals. Tramadol may be a useful medication for treating opioid withdrawal.


Related Articles

  • Receptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G Polymorphism. Robinson, J Elliott; Vardy, Eyal; DiBerto, Jeffrey F; Chefer, Vladimir I; White, Kate L; Fish, Eric W; Chen, Meng; Gigante, Eduardo; Krouse, Michael C; Sun, Hui; Thorsell, Annika; Roth, Bryan L; Heilig, Markus; Malanga, C J // Neuropsychopharmacology;Oct2015, Vol. 40 Issue 11, p2614 

    The OPRM1 A118G polymorphism is the most widely studied μ-opioid receptor (MOR) variant. Although its involvement in acute alcohol effects is well characterized, less is known about the extent to which it alters responses to opioids. Prior work has shown that both electrophysiological and...

  • Adjunct dipyrone in association with oral morphine for cancer-related pain: the sooner the better. José Duarte Souza; Hélio Pinczowski; Duarte Souza, José F; Lajolo, Paula P; Pinczowski, Hélio; Del Giglio, Auro // Supportive Care in Cancer;Nov2007, Vol. 15 Issue 11, p1319 

    Abstract Introduction  Adjunct nonopioid analgesics may improve pain control in patients with cancer needing morphine or its derivates. Dypirone is a cheap nonopioid analgesic widely used in many countries. Objective  The objective of the study was to evaluate,...

  • Pain Control Via Opioid Analgesic- Local Anesthetic Loaded IPNs. Keskin, Dilek Sendi; Wise, Donald L.; Hasirci, Vasif // Current Drug Delivery;Mar2004, Vol. 1 Issue 1, p57 

    Relief of chronic pain is an important clinical problem requiring special care and approaches. The present study was designed for the construction of a controlled release system for local application of analgesics (hydromorphone (HM), morphine (M), and codeine (C)) and a local anesthetic,...

  • Be bold and be sensible. Smith, Richard // BMJ: British Medical Journal (International Edition);9/6/2003, Vol. 327 Issue 7414, p510 

    Presents a preview of the September 6, 2003 issue of the "British Medical Journal" and discusses the character trait of boldness within the medical field. Warning from the Global Initiative on Chronic Obstructive Lung Disease against using opioids in managing patients with dyspnoea and chronic...

  • Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat. Shippenberg, Toni S.; Funada, Masahiko; Schutz, Christian G. // Psychopharmacology;2000, Vol. 151 Issue 4, p351 

    Abstract Objectives: An unbiased place preference conditioning procedure was used to examine the influence of the non-opioid peptide, dynorphin A 2-17 (DYN 2-17), upon the conditioned and unconditioned effects of opiate withdrawal in the rat. Methods: Rats were implanted SC with two pellets...

  • Tricyclics and opioids effective for the treatment of postherpetic neuralgia. Fox, Chester H. // Journal of Family Practice;Jul2003, Vol. 52 Issue 7, p517 

    Both tricyclic antidepressants (TCAs) and opioids are more effective than placebo for the treatment of postherpetic neuralgia. Although there was a trend toward greater pain relief with opioids, their use was associated with a higher dropout rate. Since response to one medicine did not reliably...

  • PARAVERTEBRAL ROPIVACAINE 0.5 PERCENT VERSUS SALINE INFILTRATION ON POSTOPERATIVE PAIN SCORES AND REQUIREMENT OF RESCUE ANALGESIC. Bhat, Imran; Ganie, Farooq Ahmad; Velayat, Buch; Maqbool, Asif; Farooqi, Ayaz // Journal of Pharmaceutical & Scientific Innovation;Jul/Aug2013, Vol. 2 Issue 4, p82 

    This study was designed to determine whether ropivacane decreases the severity of acute post-thoracotomy pain scores and whether ropivacane decreases the dosage and need of rescue analgesics in comparison with placebo. In our study Patients were randomly assigned in a blinded fashion to receive...

  • Intra-articular morphine or neostigmine does not assure better pain relief. Svediene, Saule; Andrijauskas, Audrius; Ivaskevicius, Juozas // Central European Journal of Medicine;Oct2011, Vol. 6 Issue 5, p645 

    Background and Objectives: Choice of optimal postoperative analgesia technique remains challenging. Our double - blind randomized prospective clinical study compares efficacy of end-of- surgery intra-articular application of morphine or neostigmine after anterior crutiate ligament repair....

  • Placebo Effect: The Brain and Pain.  // Alternative Medicine Alert;Jan2006, Vol. 9 Issue 1, p12 

    Discusses research being done on the physiological effect of placebo on the human brain. Reference to study by J.-K. Zubieta et al, which appeared in the 2005 issue of the "Journal of Neuroscience"; Determination of the placebo effects mediated by endogenous opioid activity; Findings of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics